Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
21 May 2019 | Story Xolisa Mnukwa | Photo Charl Devenish
Bloem Campus Open Day 2019
2020 Prospective Students get a taste of varsity life at UFS Bloemfontein Campus Open Day.

Photo Gallery

Matric learners from all over South Africa, together with their parents, teachers, and some Grade 11 learners, attended the University of the Free State (UFS) Bloemfontein Campus 2019 Open Day on 11 May, to investigate whether the UFS can meet their expectations and spark a dream concerning their careers.

A glimpse of what prospective first-years can expect in 2020

The UFS has seven faculties: Economic and Management Sciences, Education, Health Sciences, the Humanities, Law, Natural and Agricultural Sciences, Theology and Religion, and an additional Open and Distance Learning on its South Campus, and the Business School. On Open Day, learners had the opportunity to attend faculty exhibitions offering course information, teaching aids, models, and much more, demonstrating the high calibre of teaching and learning facilities at the UFS, as well as innovation and technology-based education. Learners were also exposed to interaction with academics and the deans of the faculties, motivational talks by senior students in the respective faculties, as well as members from the Student Representative Council (SRC), Kovsie FM, Student Wellness, the UFS Student Library, and Student Recruitment Services.

Why study at the UFS?

According to an honours lecturer in the UFS Department of Architecture (Faculty of Natural and Agricultural Sciences), the UFS, just like any other South African university, would be an obvious choice of study for students interested in architecture, because it is accredited by the South African Council for the Architectural Profession, as well as internationally. However, what sets the UFS apart, is the fact that lecturers have close working relationships with their students in the department, allowing them to track and understand their students’ work, academic progress, and skills development. The Department of Architecture, just like other departments in the seven faculties of study offered at the UFS, pride themselves on selecting top-tier learners to pursue their studies and moulding them into competitive professionals who will thrive in the working world. 

The UFS prides itself on being a research-led, student-centred, and regionally engaged university that aims to produce globally competitive graduates through a renewed and transformed curriculum.
 
Seventeen-year-old Zwelethu Ndabezitha from Phoenix in KwaZulu-Natal, who wants to become a quantity surveyor, said: “I want to apply everything I’ve learned into rebuilding and transforming my home town”. Learners such as Zwelethu stand a chance to realise their dreams and develop by means of dynamic scientific education, as well as independent and critical thought-enhancing education provided by the UFS.

For more information about pursuing studies at the UFS, visit the UFS prospective students’ website where learners can also apply online.

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept